# FDA Inspection 1021316 - Alina S. Agafina - July 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/alina-s-agafina/246e11e4-1684-4736-8c48-46de60f894e5
Source feed: FDA_Inspections

> FDA Inspection 1021316 for Alina S. Agafina on July 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021316
- Company Name: Alina S. Agafina
- Inspection Date: 2017-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 782566 - 2012-04-06](https://www.keypedia.com/records/fda_inspections/alina-s-agafina/4e068a85-3bcf-4b8d-8339-009746bdd255)

Company: https://www.keypedia.com/companies/alina-s-agafina/787f0167-39bd-4ebe-a96c-ccceb7d532f7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c